Literature DB >> 12511727

Chronic obstructive pulmonary disease . 6: The aetiology of exacerbations of chronic obstructive pulmonary disease.

A J White1, S Gompertz, R A Stockley.   

Abstract

Exacerbations of COPD are thought to be caused by interactions between host factors, bacteria, viruses, and changes in air quality to produce increased inflammation in the lower airway. The evidence for this and the potential mechanisms by which they result in the characteristic symptoms of exacerbations is reviewed. A better understanding of the causes and processes is needed for the appropriate use of existing treatments and the development of new ones. Future studies need to define populations clearly, stratify for known confounding factors, and should aim to identify clinical correlates so that clinical practice can be modified appropriately.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12511727      PMCID: PMC1746462          DOI: 10.1136/thorax.58.1.73

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  122 in total

1.  Intraluminal airway inflammation in chronic bronchitis. Characterization and correlation with clinical parameters.

Authors:  A B Thompson; D Daughton; R A Robbins; M A Ghafouri; M Oehlerking; S I Rennard
Journal:  Am Rev Respir Dis       Date:  1989-12

2.  Antibiotics are associated with lower relapse rates in outpatients with acute exacerbations of COPD.

Authors:  S G Adams; J Melo; M Luther; A Anzueto
Journal:  Chest       Date:  2000-05       Impact factor: 9.410

3.  Airways inflammation in chronic bronchitis: the effects of smoking and alpha1-antitrypsin deficiency.

Authors:  A T Hill; D L Bayley; E J Campbell; S L Hill; R A Stockley
Journal:  Eur Respir J       Date:  2000-05       Impact factor: 16.671

4.  Interaction of nontypable Haemophilus influenzae with human respiratory mucosa in vitro.

Authors:  R C Read; R Wilson; A Rutman; V Lund; H C Todd; A P Brain; P K Jeffery; P J Cole
Journal:  J Infect Dis       Date:  1991-03       Impact factor: 5.226

5.  Characterization of distal bronchial microflora during acute exacerbation of chronic bronchitis. Use of the protected specimen brush technique in 54 mechanically ventilated patients.

Authors:  J Y Fagon; J Chastre; J L Trouillet; Y Domart; M C Dombret; M Bornet; C Gibert
Journal:  Am Rev Respir Dis       Date:  1990-11

Review 6.  Toward a consensus definition for COPD exacerbations.

Authors:  R Rodriguez-Roisin
Journal:  Chest       Date:  2000-05       Impact factor: 9.410

7.  Bronchodilators in patients with chronic obstructive pulmonary disease on mechanical ventilation. Utilization of metered-dose inhalers.

Authors:  A Fernandez; A Lazaro; A Garcia; C Aragon; E Cerda
Journal:  Am Rev Respir Dis       Date:  1990-01

8.  Severe exacerbations of COPD and asthma. Incremental benefit of adding ipratropium to usual therapy.

Authors:  D M Patrick; R E Dales; R M Stark; G Laliberte; G Dickinson
Journal:  Chest       Date:  1990-08       Impact factor: 9.410

9.  The course and prognosis of different forms of chronic airways obstruction in a sample from the general population.

Authors:  B Burrows; J W Bloom; G A Traver; M G Cline
Journal:  N Engl J Med       Date:  1987-11-19       Impact factor: 91.245

10.  Effect of three different bronchodilators during an exacerbation of chronic obstructive pulmonary disease.

Authors:  P Lloberes; L Ramis; J M Montserrat; J Serra; J Campistol; C Picado; A Agusti-Vidal
Journal:  Eur Respir J       Date:  1988-06       Impact factor: 16.671

View more
  51 in total

Review 1.  COPD exacerbations.5: management.

Authors:  R Rodríguez-Roisin
Journal:  Thorax       Date:  2006-06       Impact factor: 9.139

2.  Respiratory viruses augment the adhesion of bacterial pathogens to respiratory epithelium in a viral species- and cell type-dependent manner.

Authors:  Vasanthi Avadhanula; Carina A Rodriguez; John P Devincenzo; Yan Wang; Richard J Webby; Glen C Ulett; Elisabeth E Adderson
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

Review 3.  COPD exacerbations . 2: aetiology.

Authors:  E Sapey; R A Stockley
Journal:  Thorax       Date:  2006-03       Impact factor: 9.139

4.  A Prospective Study of Bacteriological Etiology in Hospitalized Acute Exacerbation of COPD Patients: Relationship with Lung Function and Respiratory Failure.

Authors:  Ashok Kuwal; Vinod Joshi; Naveen Dutt; Surjit Singh; Kailash Chand Agarwal; Gopal Purohit
Journal:  Turk Thorac J       Date:  2017-11-29

5.  Comparison of air pollutant-related hospitalization burden from AECOPD in Shijiazhuang, China, between heating and non-heating season.

Authors:  Fangfang Qu; Feifei Liu; Huiran Zhang; Lingshan Chao; Jitao Guan; Rongqin Li; Fengxue Yu; Xixin Yan
Journal:  Environ Sci Pollut Res Int       Date:  2019-08-28       Impact factor: 4.223

6.  Guidelines for diagnosis and management of chronic obstructive pulmonary disease: Joint ICS/NCCP (I) recommendations.

Authors:  Dheeraj Gupta; Ritesh Agarwal; Ashutosh Nath Aggarwal; V N Maturu; Sahajal Dhooria; K T Prasad; Inderpaul S Sehgal; Lakshmikant B Yenge; Aditya Jindal; Navneet Singh; A G Ghoshal; G C Khilnani; J K Samaria; S N Gaur; D Behera
Journal:  Lung India       Date:  2013-07

7.  Non-typeable Haemophilus influenzae protects human airway epithelial cells from a subsequent respiratory syncytial virus challenge.

Authors:  Stacey M Hartwig; Margaret Ketterer; Michael A Apicella; Steven M Varga
Journal:  Virology       Date:  2016-08-27       Impact factor: 3.616

8.  Assessing treatment effects of inhaled corticosteroids on medical expenses and exacerbations among COPD patients: longitudinal analysis of managed care claims.

Authors:  Manabu Akazawa; Sally C Stearns; Andrea K Biddle
Journal:  Health Serv Res       Date:  2008-07-29       Impact factor: 3.402

Review 9.  Chronic obstructive pulmonary disease: an update on diagnosis and management issues in older adults.

Authors:  Shoab A Nazir; Marcia L Erbland
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

10.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.